I wonder if it somehow dampens our image (and stock price!) at some point or in some way... Once upon a time we had far and away the liveliest and most educational of all the biotech boards ...or any board, actually.. Funny and fact-filled with 50 or 60 hyper-engaged clever and articulate participants. But now that the company has become what we all expected of it, that board has about five participants - uneducated run of the mill crackpots shouting the current angry political cliches at each other, occasionally interrupted by moans or cheers depending on the day's stock moves. The one guy from the old board who's still there is an American living in Thailand (as once was I) - where I hope he is not teaching English there, but, these days, I wouldn't be surprised if he was!!

Not sure this copy and paste from him is news. Not sure WHAT it is. But it might be something....:

-------------------------------------------------------------------------------
Kim
13 hours ago

The trial with research medicine ( left from initial trial)for LGMD , that was guided by DI has started, it is not posted on clinical trials yet.

-----------------------------------------------------------------------------------